Cardlytics, Inc. — Director's Dealing 2020

May 28, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2020-05-27

Reporting Person: Adams David Leslie (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-27	Common Stock	M	5000	$20	Acquired	28972	Direct
2020-05-27	Common Stock	S	5000	$64.38	Disposed	23972	Direct
2020-05-28	Common Stock	M	5000	$20	Acquired	28972	Direct
2020-05-28	Common Stock	S	5000	$65.01	Disposed	23972	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-27	Stock Option (Right to Buy)	$20.0	M	5000	Disposed	2026-06-15	Common Stock (5000.0)	Direct
2020-05-28	Stock Option (Right to Buy)	$20.0	M	5000	Disposed	2026-06-15	Common Stock (5000.0)	Direct

Footnotes

F1: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.111, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

F2: Fully vested.